Traditionally, medicinal research has focused on small compounds, but amino acid collaborations are increasingly gaining traction. This new approach embraces combining peptidic sequences with alternative therapeutic techniques to tackle challenging disease targets. By leveraging the distinctive characteristics of peptidic compounds – such as sign